Cogent Biosciences Secures $475M to Advance Precision Therapies
Dateline — WALTHAM, Mass. and BOULDER, Colo., November 11, 2025:Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company developing precision...
biotech financing
Advertisement
Relmada Secures $100 Million to Accelerate CNS and Oncology Pipeline Expansion
CORAL GABLES, Fla., November 4, 2025 — Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage biopharmaceutical company focused on developing...
Tubulis Secures €344 M Series C to Accelerate ADC Clinical Growth
Munich, Germany, October 30, 2025 — Tubulis GmbH announced the successful second and final closing of its Series C...
Advertisement
